Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
McKesson
Medtronic
Colorcon
AstraZeneca

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Muro Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for MURO, and what generic and branded alternatives to MURO drugs are available?

MURO has five approved drugs.



Summary for Muro
US Patents:0
Tradenames:4
Ingredients:4
NDAs:5

Drugs and US Patents for Muro

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-001 Dec 23, 1992 DISCN No No   Start Trial   Start Trial
Muro LIQUID PRED prednisone SYRUP;ORAL 087611-002 Sep 7, 1982 DISCN No No   Start Trial   Start Trial
Muro PRELONE prednisolone SYRUP;ORAL 089654-001 Jan 17, 1989 DISCN No No   Start Trial   Start Trial
Muro PROMETA metaproterenol sulfate SYRUP;ORAL 072023-001 Sep 15, 1988 DISCN No No   Start Trial   Start Trial
Muro PROMETA metaproterenol sulfate SOLUTION;INHALATION 073340-001 Mar 30, 1992 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Muro

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-002 Dec 23, 1992 4,751,071   Start Trial
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-001 Dec 23, 1992 4,751,071   Start Trial
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-001 Dec 23, 1992 4,777,049   Start Trial
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-001 Dec 23, 1992 4,851,229   Start Trial
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-002 Dec 23, 1992 4,851,229   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Mallinckrodt
McKinsey
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.